Search
Close this search box.

OECD 474: In Vivo Micronucleus Test

Service information

An additional offering from Scantox is the OECD 474: In Vivo Micronucleus Assay Test, which allows the testing of clastogenicity and aneugenicity in vivo. The in vivo micronucleus assay is the most commonly used in vivo genotoxicity study type (e.g., pharmaceutical and agrochemical active ingredient registrations) and is typically used as a follow-up for in vitro micronucleus or in vitro chromosome aberration positives to determine if the observed in vitro activity is expressed in vivo.

Working within the facilities at Alderley Park, Scantox can deliver guideline-compliant GLP in vivo micronucleus studies. Together with GLP-compliant partners, analytical services to demonstrate systemic exposure and test item formulation analysis can also be provided.

Our study director and the team have many years of previous experience with rodent micronucleus studies.

Test species and strainWistar Han rat
OECD guideline474
Dosing regime2 doses, 24 hours apart
ScoringBone marrow (slide scored)
Formulation Analysis & Proof of ExposureAvailable upon request
EndpointIn vivo structural and nummercial chromosomal damage